Indinavir

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 3: Line 3:
* Marketed By:<br />
* Marketed By:<br />
* Major Indication: [[Human Immunodeficiency Virus]] Infection<br />
* Major Indication: [[Human Immunodeficiency Virus]] Infection<br />
-
* Drug Class: [[HIV-1 protease|HIV Protease]] Inhibitor
+
* Drug Class: [[HIV Protease]] Inhibitor
* Date of FDA Approval (Patent Expiration): <br />
* Date of FDA Approval (Patent Expiration): <br />
* 2006 Sales:
* 2006 Sales:

Revision as of 18:45, 1 December 2010

Drag the structure with the mouse to rotate

Better Known as:

Mechanism of Action

Pharmacokinetics

HIV Protease Inhibitor Pharmacokinetics
Parameter Ritonavir Tipranavir Indinavir Saquinavir Amprenavir Foxamprenavir Lopinavir Ritonavir Darunavir Atazanavir Nelfinavir
Tmax (hr) Ritonavir Tipranavir Indinavir Saquinavir Amprenavir Foxamprenavir Lopinavir Ritonavir Darunavir Atazanavir Nelfinavir
Cmax (ng/ml) Ritonavir Tipranavir Indinavir Saquinavir Amprenavir Foxamprenavir Lopinavir Ritonavir Darunavir Atazanavir Nelfinavir
Bioavailability (%) Ritonavir Tipranavir Indinavir Saquinavir Amprenavir Foxamprenavir Lopinavir Ritonavir Darunavir Atazanavir Nelfinavir
Protein Binding (%) Ritonavir Tipranavir Indinavir Saquinavir Amprenavir Foxamprenavir Lopinavir Ritonavir Darunavir Atazanavir Nelfinavir
T1/2 (hr) Ritonavir Tipranavir Indinavir Saquinavir Amprenavir Foxamprenavir Lopinavir Ritonavir Darunavir Atazanavir Nelfinavir
AUC (ng/ml/hr) Ritonavir Tipranavir Indinavir Saquinavir Amprenavir Foxamprenavir Lopinavir Ritonavir Darunavir Atazanavir Nelfinavir
IC50 (nM) Ritonavir Tipranavir Indinavir Saquinavir Amprenavir Foxamprenavir Lopinavir Ritonavir Darunavir Atazanavir Nelfinavir
Dosage (mg) Ritonavir Tipranavir Indinavir Saquinavir Amprenavir Foxamprenavir Lopinavir Ritonavir Darunavir Atazanavir Nelfinavir
Metabolism Ritonavir Tipranavir Indinavir Saquinavir Amprenavir Foxamprenavir Lopinavir Ritonavir Darunavir Atazanavir Nelfinavir


References


Proteopedia Page Contributors and Editors (what is this?)

David Canner, Alexander Berchansky, Michal Harel

Personal tools